Wall Street analysts see 113.34% upside potential for Avalo Therapeutics stock

qz.com

Wall Street analysts predict a 113.34% upside for Avalo Therapeutics (AVTX) stock. The average price target is $37.89, with estimates ranging from $24.00 to $50.00. Analysts show strong agreement on the company's earnings prospects. Avalo Therapeutics (AVTX) currently trades at $17.76 and has a Zacks Rank #2 (Buy), indicating positive earnings estimate revisions.


With a significance score of 1, this news ranks in the top 65% of today's 33016 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Wall Street analysts see 113.34% upside potential for Avalo Therapeutics stock | News Minimalist